Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Clinical trial NCT02065882 · COMPLETED

Trial details

NCT number: NCT02065882
Sponsor: Biotest
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Afibrinogenemia Congenital Hypofibrinogenemia

Start date: 2013-03-01
Primary completion: 2020-05-18
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.